Board Meeting30 May 2026, 07:41 pm
Evoq Remedies Approves Audited Financials for FY26
AI Summary
Evoq Remedies Ltd's Board of Directors approved the audited financial results for the half year and year ended March 31, 2026, during a meeting held on May 30, 2026. The board also approved the appointment of M/s. Jay Pandya & Associates as Secretarial Auditor for the financial year 2025-26. The meeting commenced at 04:00 P.M. and concluded at 07:15 P.M.
Key Highlights
- Audited financial results for the half year and year ended March 31, 2026, approved.
- M/s. Jay Pandya & Associates appointed as Secretarial Auditor for FY 2025-26.
- Board meeting held on May 30, 2026, to approve the results and appointment.
Price Impact
More from EVOQ